Date of webinar: December 1, 2023
Webinar details: Restrictive or liberal transfusion strategy in myocardial infarction and anemia
Key takeaways
- The MINT trial did not demonstrate a statistically significant difference in the rate of 30-day death or recurrent MI in patients with acute MI and anemia assigned to a restrictive compared to a liberal transfusion strategy
- While not statistically significant, the point estimates for the primary outcome and secondary outcomes consistently favored a liberal transfusion strategy
- Heart failure and other safety outcomes were comparable in the restrictive and liberal transfusion groups
Publication
Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia | NEJM
Webinar recording
Resources and tools to support practice change
1. Questions and answers - Restrictive or liberal transfusion strategy in myocardial infarction and anemia
153.09 KB